Gf Fund Management Co. Ltd. Syndax Pharmaceuticals Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,186 shares of SNDX stock, worth $30,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,186
Previous 1,792
21.99%
Holding current value
$30,931
Previous $23.7 Million
13.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
235Shares Held
92.7MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$121 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$112 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$84.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$75.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$69.1 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $800M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...